Considerations When Transferring Clinical Investigation Oversight to Another IRB: Guidance for IRBs, Clinical Investigators, and Sponsors
Information
Type
Guidance
Regulated products
Biologics, Drugs, Medical Devices
Topics
Good Clinical Practice (GCP)
Published
May 23, 2014
Last updated
May 7, 2020
Description
Guidance document on transferring clinical investigation oversight to another IRB, providing considerations for IRBs, investigators, and sponsors.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)